Programmed Death Receptor-1-directed Antibody Interactions [MoA] - N0000191259

Pharmacologic Class Information

Pharmacologic Code N0000191259
Pharmacologic Name Programmed Death Receptor-1-directed Antibody Interactions
Pharmacologic Uses
  • human programmed death receptor-1 (PD-1)-blocking antibody
  • programmed death receptor-1 (PD-1)-blocking antibody
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Programmed Death Receptor-1-directed Antibody Interactions

The following table contains 9 products whose active ingredient are classified under the same pharmacologic class Programmed Death Receptor-1-directed Antibody Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0003-3734Opdivo Non-Proprietary Name: NivolumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-3756Opdivo Non-Proprietary Name: NivolumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-3772Opdivo Non-Proprietary Name: NivolumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-3774Opdivo Non-Proprietary Name: NivolumabInjectionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-7125Opdualag Non-Proprietary Name: Nivolumab And Relatlimab-rmbwInjectionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0006-3026Keytruda Non-Proprietary Name: PembrolizumabInjection, SolutionIntravenousMerck Sharp & Dohme LlcACTIVE
0173-0898Jemperli Non-Proprietary Name: DostarlimabInjectionIntravenousGlaxosmithkline LlcACTIVE
50242-917Tecentriq Non-Proprietary Name: AtezolizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-918Tecentriq Non-Proprietary Name: AtezolizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE